Your browser doesn't support javascript.
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks?
Vitiello, Antonio; Ferrara, Francesco; Porta, Raffaele La.
  • Vitiello A; Pharmaceutical Department, Usl Umbria 1, XIV Settembre Street, 06121, Perugia, Italy. antonio.vitiello2@uslumbria1.it.
  • Ferrara F; Pharmaceutical Department, Usl Umbria 1, XIV Settembre Street, 06121, Perugia, Italy.
  • Porta R; Pathology Department, ASUR Marche, Oberdan 2 Street, 61029, Ancona, Italy.
Ir J Med Sci ; 190(4): 1637-1638, 2021 Nov.
Article in English | MEDLINE | ID: covidwho-1023353
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Ir J Med Sci Year: 2021 Document Type: Article Affiliation country: S11845-020-02482-2

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Adenosine Monophosphate / Alanine / COVID-19 Drug Treatment Type of study: Prognostic study Limits: Humans Language: English Journal: Ir J Med Sci Year: 2021 Document Type: Article Affiliation country: S11845-020-02482-2